The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Quest Diagnostics, Inc. shares valued at $706,313 were sold by PREVOZNIK MICHAEL E on Feb 29 ’24. At $125.88 per share, PREVOZNIK MICHAEL E sold 5,611 shares. The insider’s holdings dropped to 38,478 shares worth approximately $5.21 million following the completion of this transaction.
Also, Doherty Catherine T. sold 1,187 shares, netting a total of over 149,420 in proceeds. Following the sale of shares at $125.88 each, the insider now holds 68,412 shares.
Before that, Doherty Catherine T. had sold 5,557 shares from its account. In a trade valued at $703,349, the EVP, Regional Businesses traded Quest Diagnostics, Inc. shares for $126.57 each. Upon closing the transaction, the insider’s holdings decreased to 5,557 shares, worth approximately $9.43 million.
As published in their initiating research note from Leerink Partners on February 26, 2024, Quest Diagnostics, Inc. [DGX] has been a Market perform and the price target has been revised to $135. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of January 03, 2024, Barclays has initiated its “an Equal weight” rating for DGX. Earlier on December 12, 2023, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for DGX stock which previously was a “a Neutral”.
Analyzing DGX Stock Performance
During the last five days, there has been a surge of approximately 7.55%. Over the course of the year, Quest Diagnostics, Inc. shares have dropped approximately -1.78%. Shares of the company reached a 52-week high of $143.63 on 01/02/24 and a 52-week low of $123.04 on 02/01/24. A 50-day SMA is recorded $128.81, while a 200-day SMA reached $131.23. Nevertheless, trading volume fell to 1.02 million shares from 1.57 million shares the previous day.
Support And Resistance Levels for Quest Diagnostics, Inc. (DGX)
According to the 24-hour chart, there is a support level at 133.50, which, if violated, would cause prices to drop to 131.57. In the upper region, resistance lies at 137.98. The next price resistance is at 140.53. RSI (Relative Strength Index) is 61.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 5.83, which suggests the price will increase in the coming days. Percent R is at 25.87%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
